Nuestros recursos

Lycored, a leader in carotenoid-based wellness products, sought to understand the consumer-perceived efficacy of a tomato-based supplement through twelve subjective skin indicators.

In this post, we provide a comprehensive breakdown of the key challenges and opportunities associated with virtual clinical trials, examining the nuances of virtual components and how their implementation might affect each stage and touchpoint of the clinical trial journey.

Clinical trial sponsors are constantly seeking ways to collect better data, faster—accelerating clinical trials. Meanwhile, patients are increasingly likely to access healthcare services and interact with healthcare professionals digitally. Growing usage of telehealth also impacts patients’ expectations of clinical trials, with convenience and accessibility taking center stage.

Hybrid clinical trials drive efficiency, engagement, and effectiveness in clinical research. See whether a hybrid model could be a fit for your upcoming study.

ObvioHealth highlight the benefits of incorporating DCTs, as well as the challenges associated with DCTs, and call out specific use cases for DCTs.

ObvioHealth announces it has been rated as the top “major contender” on Everest Group’s 2022 PEAK Matrix®, an industry report providing analysis and insights on decentralized clinical trial vendors. ObvioHealth is ranked 5th overall in a field of 24 industry players.

ObvioHealth, a global Virtual Research Organization (VRO) pioneering end-to-end decentralized clinical trials (DCT), is collaborating with Oracle in Asia Pacific to help get breakthrough therapies to market faster through more efficient integration of diverse data sets. The alliance will enable the rapid collection, integration and analysis of multi-source data collected from sites, patients, devices and labs.

We know that a patient-centric approach to clinical trials generally leads to higher compliance and retention rates. DCTs are more convenient for participants.